Scalp Cooling Therapy for Chemotherapy-Induced Hair Loss in Asian Patients with Breast or Gynecological Cancers – A Tertiary Institution Experience
March 2024
in “
Research Square (Research Square)
”
TLDR Scalp cooling therapy helps preserve hair during chemotherapy for most patients.
Scalp cooling therapy (SCT) was evaluated in 83 Asian women with breast or gynecological cancers undergoing chemotherapy at a tertiary institution. The study, conducted over 18 months, involved 510 SCT cycles using the Paxman system. Results showed that 94% of patients found SCT comfortable. Hair preservation success was highest in patients receiving weekly paclitaxel (76.7%) and lower in those on a 3-weekly paclitaxel regimen (50%) or anthracycline and cyclophosphamide (5.3%). Overall, SCT was well tolerated and significantly improved hair preservation or regrowth compared to historical controls.